Cargando…
Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
BACKGROUND: The pathological complete response of neoadjuvant chemotherapy for breast cancer correlates with the prognosis for survival. Tumors may have different prognoses according to their molecular subtypes. This study was performed to evaluate the relevance of the pathological response and prog...
Autores principales: | Zhao, Yue, Dong, Xiaoqiu, Li, Rongguo, Ma, Xiao, Song, Jian, Li, Yingjie, Zhang, Dongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480585/ https://www.ncbi.nlm.nih.gov/pubmed/26150728 http://dx.doi.org/10.2147/OTT.S83243 |
Ejemplares similares
-
Correlation Between Clinical-Pathologic Factors and Long-Term Follow-Up in Young Breast Cancer Patients
por: Zhao, Yue, et al.
Publicado: (2015) -
Conversion of immunohistochemical markers and breast density are associated with pathological response and prognosis in very young breast cancer patients who fail to achieve a pathological complete response after neoadjuvant chemotherapy
por: Zhao, Yue, et al.
Publicado: (2019) -
Pathological Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: The Relationship Between Inflammatory Biomarkers and Molecular Subtypes
por: Kaytaz Tekyol, Kübra, et al.
Publicado: (2021) -
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
por: Santonja, Angela, et al.
Publicado: (2018) -
Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)